XTL Biopharmaceuticals Ltd
XTLB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023549
No open-market purchases or sales by XTL Biopharmaceuticals Ltd insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $20.7K in total; no superinvestor holds it.
Holders of 5% or more of XTLB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of XTL Biopharmaceuticals Ltd, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of XTL Biopharmaceuticals Ltd on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on XTL Biopharmaceuticals Ltd, newest first.
No Schedule 13D or 13G filings on XTL Biopharmaceuticals Ltd are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell XTL Biopharmaceuticals Ltd shares.
No Form 144 notices for XTL Biopharmaceuticals Ltd are on file.